British Journal of Clinical Pharmacology · 2017 · 28 citations · 32 references
MedicineDermatologyPharmacologyClinical PharmacologyPain ManagementPain MedicineAnalgesiaAnalgesic PharmacologyNociceptive PainPain AssessmentPain MeasurementSkin IrritationClinical Trials Of AnalgesicsCutaneous Sensory TestingNociceptive Pain PharmacotherapyPain PharmacologyPharmacodynamics Of AnalgesicsPharmacological Pain ReliefPredictive ValidityWilliams Designs
AIMS: The aim of the present study was to assess the predictivity of laser-(radiant-heat)-evoked potentials (LEPs) from the vertex electroencephalogram, using an algesimetric procedure, testing the anti-nociceptive/anti-hyperalgesic effects of single oral doses of four marketed analgesics (of different compound classes) vs. placebo, in healthy volunteers with three skin types. METHODS: laser-induced painful stimuli to normal, ultraviolet (UV) B-inflamed and capsaicin-irritated skin. LEPs and visual analogue scale ratings were taken at baseline and hourly for 6 h postdose from all three skin types. RESULTS: In normal skin, the averaged postdose LEP peak-to-peak-(PtP)-amplitudes were reduced by pregabalin (-2.68 μV; 95% confidence interval (CI) -4.16, 1.19) and duloxetine (-1.73 μV; 95% CI -3.21, -0.26) but not by lacosamide and celecoxib vs. placebo. On UVB-irradiated skin, reflecting inflammatory pain, celecoxib induced a pronounced reduction in LEP PtP amplitudes vs. placebo (-6.2 μV; 95% CI -7.88, -4.51), with a smaller reduction by duloxetine (-4.54 μV; 95% CI -6.21, -2.87) and pregabalin (-3.72 μV; 95% CI -5.40, -2.04), whereas lacosamide was inactive. LEP PtP amplitudes on capsaicin-irritated skin, reflecting peripheral/spinal sensitization, as in neuropathic pain, were reduced by pregabalin (-3.78 μV; 95% CI -5.31, -2.25) and duloxetine (-2.32 μV; 95% CI -3.82, -0.82) but not by celecoxib or lacosamide vs. placebo, which was in agreement with known clinical profiles. Overall, PtP amplitude reductions were in agreement with subjective ratings. CONCLUSIONS: LEP algesimetry is sensitive to analgesics with different modes of action and may enable the effects of novel analgesics to be assessed during early clinical development.
32
Christopher Southan, Joanna L Sharman, Helen E. Benson et al. · Nucleic Acids Research · 2015 · 1K citations · Full text
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
S P H Alexander, Doriano Fabbro, Eamonn Kelly et al. · British Journal of Pharmacology · 2015 · 603 citations · Full text